Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (31)

2024

  1. Acute Hepatitis in Children Due to Rat Hepatitis E Virus

    Journal of Pediatrics, Vol. 273

  2. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1

  3. Assessment of performance and comparison of three commercial HDV RNA detection assays: implications for diagnosis and treatment monitoring

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  4. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)

    npj Vaccines

  5. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  6. Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study

    Infection

  7. Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. e917-e928

  8. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

  9. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

    Emerging Microbes and Infections, Vol. 13, Núm. 1

  10. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

    npj Vaccines, Vol. 9, Núm. 1

  11. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802

  12. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

  13. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

2023

  1. A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination

    Liver International

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. A tetracationic porphyrin with dual anti-prion activity

    iScience, Vol. 26, Núm. 9

  4. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 307-317

  5. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

    Journal of Fungi, Vol. 9, Núm. 6

  6. Optimization of the molecular diagnosis of the acute hepatitis E virus infection

    Microbial Biotechnology, Vol. 16, Núm. 6, pp. 1325-1332

  7. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34